Skip to main content

Robotic Surgical Approach Safe, Feasible for Gallbladder Cancer

Medically reviewed by Carmen Pope, BPharm. Last updated on March 20, 2024.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, March 20, 2024 -- For patients undergoing gallbladder cancer surgery, robotic-assisted surgery has comparable oncological outcomes to open surgery, according to a review published online Feb. 27 in the American Journal of Surgery.

Sebastian Mellado, from the Boston University School of Medicine, and colleagues conducted a systematic review of the literature to compare patient outcomes following robotic, open, and laparoscopic surgeries for treatment of gallbladder cancer. Five studies with 353 patients and published between 2019 and 2023 were identified and reviewed. All studies compared robotic to open surgery: 36.5 and 63.5 percent of the patients underwent robotic and open surgery, respectively.

According to the researchers, the robotic-assisted approach is a safe and feasible option for patients with gallbladder cancer. Robotic-assisted surgery was found to be comparable to open surgery in terms of oncological outcomes, with potential advantages seen in terms of revision and postoperative recovery.

"Our study demonstrates the viability of robotic surgery for gallbladder cancer treatment, a field where minimally invasive approaches have been cautiously adopted due to concerns over oncologic efficacy and technical challenges," coauthor Eduardo Vega, M.D., also from the Boston University School of Medicine, said in a statement.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted March 2024

Read this next

Vaginal Cancer Incidence Increasing Globally

WEDNESDAY, July 3, 2024 -- The incidence of vaginal cancer is increasing globally, according to a study published online June 25 in BJOG: An International Journal of Obstetrics...

Nudging Both Clinicians, Patients May Increase Serious Illness Conversations

TUESDAY, July 2, 2024 -- Combining clinician- and patient-directed nudges may help to promote serious illness conversations (SICs) in cancer care, according to a study published...

Perioperative Chemo Improves Progression-Free Survival in Pancreatic Cancer

TUESDAY, July 2, 2024 -- For patients with resectable pancreatic ductal adenocarcinoma (PDAC), the 12-month progression-free survival (PFS) may be increased with neoadjuvant...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.